The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults.
Blood Test for Colon Cancer Screening May Miss Some Precancers, FDA Staff Says
FDA reviewers questioned the potential benefits of Guardant Health’s blood-based test for colorectal cancer (CRC) screening in documents released ahead of an advisory committee meeting